The following are some of the most common questions that healthcare professionals ask about ParaGard®. If you have questions that are not addressed here, please use the search feature below to find the answers, or call the ParaGard® Information Line at 1-877-ParaGard (727-2427).



How do I order ParaGard®?
Where can I get information on this site about inserting ParaGard®?
What if my patient needs contraception for only 5 or fewer years? Would ParaGard® still be an appropriate option?
Does the ParaGard® label contain restrictions regarding appropriate patients?
How do the discontinuation rates due to menstrual problems compare between the hormonal and nonhormal IUCs?
More


Please select a question.

Could not find your question? Please use our site specific search engine to find your answer:


ParaGard® does not protect against HIV/AIDS or other sexually transmitted infections. ParaGard® must not be used by women who are or may be pregnant; have acute pelvic inflammatory disease (PID) or current behavior suggesting a high risk for PID; have had a postpregnancy or postabortion uterine infection in the past 3 months; have cancer of the uterus or cervix; have an infection in the cervix; have an allergy to any component; or have Wilson's disease. The most common side effects of ParaGard® are heavier and longer periods and spotting between periods; for most women, these typically subside after 2 to 3 months. If a woman misses her period, she must be promptly evaluated for pregnancy. Some possible serious complications that have been associated with intrauterine contraceptives, including ParaGard®, are PID, perforation of the uterus, and expulsion.

References:

  1. Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 µg/d and the Copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. Fertil Steril. 1994;61(1):70-77.
  2. Mirena [package insert]. Wayne, NJ: Bayer HealthCare Pharmaceuticals Inc; 2008.
  3. Mircette [package insert]. Pomona, NY: Duramed Pharmaceuticals, Inc; 2005.
  4. Trussell J, Leveque JA, Koenig JD, et al. The economic value of contraception: a comparison of 15 methods.
    Am J Public Health. 1995;85(4):494-503.